SII seeks govt's nod to manufacture, stockpile qHPV vaccine against cervical cancer - ETHealthWorld

4:27am PDT - May 15th, 2022    health - The Times of India

The Serum Institute of India (SII) will soon seek market authorisation as well as a manufacturing licence from the Drugs Controller General of India (DCGI) for the Quadrivalent Human Papillomavirus (qHPV) vaccine against cervical cancer.